Management of Worsening Heart Failure With Reduced Ejection Fraction - Université de Lorraine Access content directly
Journal Articles Journal of the American College of Cardiology Year : 2023

Management of Worsening Heart Failure With Reduced Ejection Fraction

Abstract

Despite worsening heart failure (HF) being extremely common, expensive, and associated with substantial risk of death, there remain no dedicated clinical practice guidelines for the specific management of these patients. The lack of a management guideline is despite a rapidly evolving evidence-base, as a number of recent clinical trials have demonstrated multiple therapies to be safe and efficacious in this high-risk population. Herein, we propose a framework for treating worsening HF with reduced ejection fraction with the sense of urgency it deserves. This includes treating congestion; managing precipitants; and establishing a foundation of rapid-sequence, simultaneous, and/or in-hospital initiation of quadruple medical therapy for HF with reduced ejection fraction, with the top priority being at least low doses of all 4 medications. Moreover, to maximally reduce residual clinical risk, we further propose consideration of upfront simultaneous use of vericiguat (ie, quintuple medical therapy) and administration of intravenous iron for those who are iron deficient. (
Fichier principal
Vignette du fichier
1-s2.0-S0735109723058746-main.pdf (330.52 Ko) Télécharger le fichier
Origin Publication funded by an institution

Dates and versions

hal-04176512 , version 1 (03-08-2023)

Licence

Identifiers

Cite

Stephen J Greene, Johann Bauersachs, Jasper J Brugts, Justin A Ezekowitz, Gerasimos Filippatos, et al.. Management of Worsening Heart Failure With Reduced Ejection Fraction. Journal of the American College of Cardiology, 2023, 82 (6), pp.559-571. ⟨10.1016/j.jacc.2023.04.057⟩. ⟨hal-04176512⟩
9 View
74 Download

Altmetric

Share

Gmail Mastodon Facebook X LinkedIn More